Cargando…
Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction
Heart failure (HF) is a common cause of cardiovascular mortality and morbidity. Despite advances in treatment, the prognosis remains poor. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors decrease HF events by 27–39% in high-risk patients with type 2 diabetes mellitus (T2DM). Moreover, the DAPA-H...
Autores principales: | Elserafy, Ahmed S., Reda, Ashraf, Farag, Elsayed, Mostafa, Tamer, Farag, Nabil, Elbahry, Atef, Sanad, Osama, Bendary, Ahmed, Elkersh, Ahmed, Attia, Ihab, Selim, Mohammed, Khamis, Hazem, Issak, Emad R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626381/ https://www.ncbi.nlm.nih.gov/pubmed/34780022 http://dx.doi.org/10.1007/s40261-021-01095-6 |
Ejemplares similares
-
Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
por: Reda, Ashraf, et al.
Publicado: (2020) -
The Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) Perspectives on the Usage of Inclisiran
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2022) -
Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndrome: final data of the nationwide cross-sectional ‘CardioRisk’ project
por: Reda, Ashraf, et al.
Publicado: (2021) -
Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long‐Term Registry
por: Hassanein, Mahmoud, et al.
Publicado: (2018) -
Clinical characteristics and management of hospitalized and ambulatory patients with heart failure–results from ESC heart failure long‐term registry–Egyptian cohort
por: Hassanein, Mahmoud, et al.
Publicado: (2015)